Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning

Neuron

Volumn 49, Issue 4, 2006, Pages 603-615

  Kellendonk, Christoph ^a   Simpson, Eleanor H ^a   Polan, H Jonathan ^a,b   Malleret, Gaël ^a   Vronskaya, Svetlana ^a   Winiger, Vanessa ^a   Moore, Holly ^a   Kandel, Eric R ^a  

^a Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; TASK PERFORMANCE; TRANSGENE; TURNOVER TIME; WORKING MEMORY;

ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CARBON ISOTOPES; COGNITION DISORDERS; CORPUS STRIATUM; DEOXYGLUCOSE; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; N-METHYLASPARTATE; PREFRONTAL CORTEX; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RADIOLIGAND ASSAY; REACTION TIME; RECEPTORS, DOPAMINE D2; SPIPERONE; TIME FACTORS; TRITIUM;

EID: 32344435859     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2006.01.023     Document Type: Article

References (66)

1. A. Abi-Dargham, R. Gil, J. Krystal, R.M. Baldwin, J.P. Seibyl, M. Bowers, C.H. van Dyck, D.S. Charney, R.B. Innis, and M. Laruelle Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort Am. J. Psychiatry 155 1998 761 767
2. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L.S. Kegeles, R. Weiss, T.B. Cooper, J.J. Mann, and R.L. Van Heertum Increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc. Natl. Acad. Sci. USA 97 2000 8104 8109
3. A. Abi-Dargham, O. Mawlawi, I. Lombardo, R. Gil, D. Martinez, Y. Huang, D.R. Hwang, J. Keilp, L. Kochan, and R. Van Heertum Prefrontal dopamine D1 receptors and working memory in schizophrenia J. Neurosci. 22 2002 3708 3719
4. M. Akil, J.N. Pierri, R.E. Whitehead, C.L. Edgar, C. Mohila, A.R. Sampson, and D.A. Lewis Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects Am. J. Psychiatry 156 1999 1580 1589
5. G.E. Alexander, M.R. DeLong, and P.L. Strick Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu. Rev. Neurosci. 9 1986 357 381
6. K. Battig, H.E. Rosvold, and M. Mishkin Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys J. Comp. Physiol. Psychol. 53 1960 400 407
7. J.M. Birrell, and V.J. Brown Medial frontal cortex mediates perceptual attentional set shifting in the rat J. Neurosci. 20 2000 4320 4324
8. D.L. Braff, M.A. Geyer, and N.R. Swerdlow Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology (Berl.) 156 2001 234 258
9. A. Breier, T.P. Su, R. Saunders, R.E. Carson, B.S. Kolachana, A. de Bartolomeis, D.R. Weinberger, N. Weisenfeld, A.K. Malhotra, W.C. Eckelman, and D. Pickar Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method Proc. Natl. Acad. Sci. USA 94 1997 2569 2574
10. B.S. Bunney, and G.K. Aghajanian The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique Brain Res. 117 1976 423 435
11. A. Carlsson A paradigm shift in brain research Science 294 2001 1021 1024
12. A. Carlsson, and M. Lindqvist Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain Acta Pharmacol. Toxicol. (Copenh.) 20 1963 140 144
13. W.T. Carpenter, and J.M. Gold Another view of therapy for cognition in schizophrenia Biol. Psychiatry 51 2002 969 971
14. S.A. Castner, G.V. Williams, and P.S. Goldman-Rakic Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation Science 287 2000 2020 2022
15. G. Colacicco, H. Welzl, H.P. Lipp, and H. Wurbel Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation Beh. Brain Res. 132 2002 95 102
16. I. Creese, D.R. Burt, and S.H. Snyder Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 1976 481 483
17. K.L. Davis, R.S. Kahn, G. Ko, and M. Davidson Dopamine in schizophrenia: a review and reconceptualization Am. J. Psychiatry 148 1991 1474 1486
18. R. Dias, and J.P. Aggleton Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility Eur. J. Neurosci. 12 2000 4457 4466
19. I. Divac Neostriatum and functions of prefrontal cortex Acta Neurobiol. Exp. (Warsz.) 32 1972 461 477
20. S.B. Floresco, J.K. Seamans, and A.G. Phillips Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay J. Neurosci. 17 1997 1880 1890
21. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
22. J.M. Fuster Animal Neuropsysiology J.M. Fuster The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe 1997 Lippincott-Raven Philadelphia and New York 66 102
23. S.B. Glickstein, P.R. Hof, and C. Schmauss Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits J. Neurosci. 22 2002 5619 5629
24. P.S. Goldman-Rakic Working memory dysfunction in schizophrenia J. Neuropsychiatry Clin. Neurosci. 6 1994 348 357
25. P.S. Goldman-Rakic The "psychic" neuron of the cerebral cortex Ann. N Y Acad. Sci. 868 1999 13 26
26. S. Granon, F. Passetti, K.L. Thomas, J.W. Dalley, B.J. Everitt, and T.W. Robbins Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex J. Neurosci. 20 2000 1208 1215
27. A.M. Graybiel The basal ganglia: learning new tricks and loving it Curr. Opin. Neurobiol. 15 2005 638 644
28. N. Guo, D.R. Hwang, E.S. Lo, Y.Y. Huang, M. Laruelle, and A. Abi-Dargham Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia Neuropsychopharmacology 28 2003 1703 1711
29. S.N. Haber The primate basal ganglia: parallel and integrative networks J. Chem. Neuroanat. 26 2003 317 330
30. M. Hirvonen, A. Laakso, K. Nagren, J.O. Rinne, T. Pohjalainen, and J. Hietala C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo Mol. Psychiatry 9 2004 1060 1066
31. J. Hirvonen, T.G. van Erp, J. Huttunen, S. Aalto, K. Nagren, M. Huttunen, J. Lonnqvist, J. Kaprio, J. Hietala, and T.D. Cannon Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia Arch. Gen. Psychiatry 62 2005 371 378
32. G.E. Jaskiw, F. Karoum, W.J. Freed, I. Phillips, J.E. Kleinman, and D.R. Weinberger Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat Brain Res. 534 1990 263 272
33. R.S. Kahn, P.D. Harvey, M. Davidson, R.S. Keefe, S. Apter, J.M. Neale, R.C. Mohs, and K.L. Davis Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function Schizophr. Res. 11 1994 217 224
34. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia Am. J. Psychiatry 157 2000 514 520
35. M. Laruelle Imaging dopamine transmission in schizophrenia. A review and meta-analysis Q. J. Nucl. Med. 42 1998 211 221
36. M. Laruelle, A. Abi-Dargham, C.H. van Dyck, R. Gil, C.D. D'Souza, J. Erdos, E. McCance, W. Rosenblatt, C. Fingado, and S.S. Zoghbi Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proc. Natl. Acad. Sci. USA 93 1996 9235 9240
37. B.R. Lawford, R.M. Young, C.D. Swagell, M. Barnes, S.C. Burton, W.K. Ward, K.R. Heslop, S. Shadforth, A. van Daal, and C.P. Morris The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia Schizophr. Res. 73 2005 31 37
38. I. Lee, and R.P. Kesner Time-dependent relationship between the dorsal hippocampus and the prefrontal cortex in spatial memory J. Neurosci. 23 2003 1517 1523
39. S.E. Loughlin, and J.H. Fallon Substantia nigra and ventral tegmental area projections to cortex: topography and collateralization Neuroscience 11 1984 425 435
40. H.J. Markowitsch, and M. Pritzel Comparative analysis of prefrontal learning functions in rats, cats, and monkeys Psychol. Bull. 84 1977 817 837
41. M. Mayford, M.E. Bach, Y.Y. Huang, L. Wang, R.D. Hawkins, and E.R. Kandel Control of memory formation through regulated expression of a CaMKII transgene Science 274 1996 1678 1683
42. H.Y. Meltzer What's atypical about atypical antipsychotic drugs? Curr. Opin. Pharmacol. 4 2004 53 57
43. A. Meyer-Lindenberg, R.S. Miletich, P.D. Kohn, G. Esposito, R.E. Carson, M. Quarantelli, D.R. Weinberger, and K.F. Berman Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia Nat. Neurosci. 5 2002 267 271
44. S. Miyamoto, G.E. Duncan, C.E. Marx, and J.A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol. Psychiatry 10 2005 79 104
45. A.L. Nordstrom, L. Farde, F.A. Wiesel, K. Forslund, S. Pauli, C. Halldin, and G. Uppfeldt Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients Biol. Psychiatry 33 1993 227 235
46. R.D. Oades, and G.M. Halliday Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity Brain Res. 434 1987 117 165
47. N. Ohtani, T. Goto, C. Waeber, and P.G. Bhide Dopamine modulates cell cycle in the lateral ganglionic eminence J. Neurosci. 23 2003 2840 2850
48. Y. Okubo, T. Suhara, K. Suzuki, K. Kobayashi, O. Inoue, O. Terasaki, Y. Someya, T. Sassa, Y. Sudo, and E. Matsushima Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET Nature 385 1997 634 636
49. A. Partiot, M. Verin, B. Pillon, C. Teixeira-Ferreira, Y. Agid, and B. Dubois Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation Neuropsychologia 34 1996 709 721
50. A.C. Roberts, M.A. De Salvia, L.S. Wilkinson, P. Collins, J.L. Muir, B.J. Everitt, and T.W. Robbins 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine J. Neurosci. 14 1994 2531 2544
51. N. Schaeren-Wiemers, and A. Gerfin-Moser A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes Histochemistry 100 1993 431 440
52. C. Schmitz, and P.R. Hof Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach J. Chem. Neuroanat. 20 2000 93 114
53. J.K. Seamans, and C.R. Yang The principal features and mechanisms of dopamine modulation in the prefrontal cortex Prog. Neurobiol. 74 2004 1 58
54. J.K. Seamans, S.B. Floresco, and A.G. Phillips D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat J. Neurosci. 18 1998 1613 1621
55. P. Seeman, and T. Lee Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons Science 188 1975 1217 1219
56. P. Seeman, and S. Kapur Schizophrenia: more dopamine, more D2 receptors Proc. Natl. Acad. Sci. USA 97 2000 7673 7675
57. A.J. Silva Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice Neuron 19 1997 755 759
58. D. Velakoulis, and C. Pantelis What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas Aust. N. Z. J. Psychiatry 30 1996 195 209
59. P. Voorn, L.J. Vanderschuren, H.J. Groenewegen, T.W. Robbins, and C.M. Pennartz Putting a spin on the dorsal-ventral divide of the striatum Trends Neurosci. 27 2004 468 474
60. D.R. Weinberger Implications of normal brain development for the pathogenesis of schizophrenia Arch. Gen. Psychiatry 44 1987 660 669
61. D.R. Weinberger, and K.F. Berman Prefrontal function in schizophrenia: confounds and controversies Phil. Trans. R. Soc. London B Biol. Sci. 351 1996 1495 1503
62. D.R. Weinberger, K.F. Berman, and B.P. Illowsky Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism Arch. Gen. Psychiatry 45 1988 609 615
63. M.J. West, L. Slomianka, and H.J. Gundersen Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator Anat. Rec. 231 1991 482 497
64. D.F. Wong, H.N. Wagner Jr., L.E. Tune, R.F. Dannals, G.D. Pearlson, J.M. Links, C.A. Tamminga, E.P. Broussolle, H.T. Ravert, and A.A. Wilson Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics Science 234 1986 1558 1563
65. J. Zahrt, J.R. Taylor, R.G. Mathew, and A.F. Arnsten Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance J. Neurosci. 17 1997 8528 8535
66. A. Zvara, G. Szekeres, Z. Janka, J.Z. Kelemen, C. Cimmer, M. Santha, and L. Puskas G. (2005). Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers Dis. Markers 21 2005 61 69